2,847
Total Subject Records
1,234
Completed CRFs
87
Pending Queries
99.2%
Data Quality Score
â„šī¸ Study Update: EVAL-2024-001 database lock scheduled for November 15, 2024. Please resolve all outstanding queries before the deadline.

Recent Subject Visits

Subject ID: 001-101
Visit: Week 12 Study: EVAL-2024-001 Last Entry: Nov 3, 2024
Complete
Subject ID: 001-102
Visit: Week 8 Study: EVAL-2024-001 Last Entry: Nov 2, 2024
In Progress
Subject ID: 002-045
Visit: Week 4 Study: EVAL-2024-002 Last Entry: Nov 1, 2024
Query Open
Subject ID: 001-103
Visit: Screening Study: EVAL-2024-001 Last Entry: Oct 31, 2024
Verified

Data Entry Status by Study

EVAL-2024-001 234/300 CRFs (78%)
EVAL-2024-002 145/200 CRFs (72%)
EVAL-2023-015 497/500 CRFs (99%)
EVAL-2023-012 150/150 CRFs (100%)
Open Queries (87)
Data Entry Form
Patient Outcomes
Data Validation
Query ID Subject ID Form Field Issue Opened Status Action
Q-2024-1247 001-101 Vital Signs Blood Pressure Value out of range Nov 3, 2024 Open
Q-2024-1246 002-045 Adverse Events Onset Date Missing data Nov 2, 2024 Open
Q-2024-1245 001-098 Laboratory Hemoglobin Inconsistent with previous Nov 1, 2024 Responded
Q-2024-1244 003-012 Concomitant Meds Medication Name Clarification needed Oct 31, 2024 Open

Data Entry: Demographics

Clinical Outcomes Summary

Outcome Measure Baseline Week 12 Change Status
Primary Efficacy Endpoint 45.2 38.7 ↓ 14.4% Improved
Quality of Life Score 62.5 74.3 ↑ 18.9% Improved
Adverse Event Rate N/A 12.3% - Within Range

Data Validation Rules

✓ Range Checks: All vital signs within normal ranges
✓ Consistency Checks: No conflicting data entries detected
⚠ Missing Data: 23 required fields incomplete
✓ Format Validation: All date and numeric formats correct